UBS Downgrades Kodiak Sciences to Neutral, Lowers Price Target to $4
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Eliana Merle has downgraded Kodiak Sciences (NASDAQ:KOD) from Buy to Neutral and lowered the price target from $15 to $4.
July 27, 2023 | 9:53 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kodiak Sciences has been downgraded from Buy to Neutral by UBS, with a lowered price target from $15 to $4.
The downgrade from Buy to Neutral by UBS and the significant reduction in price target from $15 to $4 indicates a less optimistic outlook for Kodiak Sciences. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100